Iceland· IS-IS/1/22/069/01
Produodopa
A foslevodopa und decarboxylasehemmer product containing foslevodopa,foscarbidopa, registered in Iceland by AbbVie A/S. The same ATC class is registered in 8 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Foslevodopa und decarboxylasehemmer is registered in 8 of 19 countries.
Countries holding a registration under ATC N04BA07 (foslevodopa und decarboxylasehemmer), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 5 of them publish a price we can compare per daily dose
Foslevodopa und decarboxylasehemmer · ATC N04BA07
8 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Foslevodopa,Foscarbidopa
- Manufacturer
- AbbVie A/S
- Country
- Iceland (IS)
- ATC code
- N04BA07
- ATC class
- Foslevodopa und Decarboxylasehemmer
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 1
1 priced- ean0613137 hgl x1 pakkiISK 115788
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Foslevodopa und decarboxylasehemmer in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaVYALEVABBVIE CORPORATION
- CzechiaDUODOPA SCAbbVie s.r.o., Praha
- GermanyProduodopaAbbvie Deutschland Gmbh & Co. Kg
- SpainDUODOPA 240 MG/ML + 12 MG/ML SOLUCION PARA PERFUSIONAbbvie Spain, S.L.U.
- FinlandProduodopaAbbVie Oy
- FranceSCYOVA 240 mg/mL + 12 mg/mL, solution pour perfusionABBVIE
- United KingdomProduodopa 2.4g/10ml / 120mg/10ml solution for infusion vialsAbbVie Ltd
- IrelandProduodopa 240 mg/ml + 12 mg/ml solution for infusionAbbVie Limited
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Produodopa
- Belgium · Produodopa
- Bulgaria · Продуодопа
- Cyprus · Produodopa
- Czechia · Duodopa Sc
- Germany · Produodopa®
- Denmark · Duodopa
- Estonia · Produodopa
- Spain · Duodopa
- Finland · Produodopa
- France · Scyova
- Greece · Produodopa
- Croatia · Produodopa
- Hungary · Produodopa
- Ireland · Produodopa
- Italy · Duodopa
- Liechtenstein · Produodopa
- Lithuania · Duodopa
- Luxembourg · Produodopa
- Netherlands · Duodopa
- Norway · Produodopa
- Poland · Produodopa
- Portugal · Duodopa
- Romania · Produodopa
- Sweden · Produodopa
- Slovenia · Produodopa
- Slovakia · Duodopa Sc
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/52ea0e82-f9f0-4e1f-805b-1d63f9a86759 GET /v1/drugs/52ea0e82-f9f0-4e1f-805b-1d63f9a86759?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Innrennslislyf, lausn",
"source": "lyfjastofnun",
"atc_raw": "N04BA07",
"marketed": true,
"strength": "240 mg/ml +12 mg/ml",
"ma_number": "IS/1/22/069/01",
"substance": "Foslevodopa,Foscarbidopa",
"other_info": "Markaðssetning á Íslandi er háð því að Lyfjastofnun hafi staðfest að sérstök skilyrði er varða öryggi og verkun við notkun lyfsins séu uppfyllt.",
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "44861"
}See everything about foslevodopa und decarboxylasehemmer.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.